Impact of preoperative nesiritide on renal function after mitral valve surgery.
Nesiritide, a recombinant B-type natriuretic peptide used for the intravenous treatment of acute decompensated congestive heart failure. Concerns have been raised about the long-term use of nesiritide, but data is scarce regarding its use in acute congestive heart failure and during cardiac surgery. We conducted a retrospective data review to address the safety of nesiritide for pretreatment of patients undergoing mitral valve surgery.
Salzberg
Sacha P
SP
Department of Cardiothoracic Surgery, Mount Sinai Medical Center, 1190 Fifth Avenue, New York, NY 10029, USA. sacha.salzberg@gmail.com
Emmert
Maximillian Y
MY
Vassalotti
Joseph
J
Nandiwada
Deepa Rani
DR
Adams
David H
DH
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D005260:Female; D006333:Heart Failure / Q000503:physiopathology / Q000517:prevention & control*; D006350:Heart Valve Prosthesis / Q000009:adverse effects*; D006801:Humans; D007668:Kidney / Q000187:drug effects* / Q000503:physiopathology*; D008297:Male; D008875:Middle Aged; D008943:Mitral Valve / Q000601:surgery*; D045283:Natriuretic Agents / Q000008:administration & dosage; D020097:Natriuretic Peptide, Brain / Q000008:administration & dosage*; D011292:Premedication / Q000379:methods*; D012189:Retrospective Studies; D055815:Young Adult
D045283:Natriuretic Agents; D020097:Natriuretic Peptide, Brain